Showing results (81-90 of 379) with videos related to

Sort By:
Pageof 38
Journal of Chromatography|March 21, 1977
Gas-liquid chromatography of methylpentynol carbamate and its metabolite 3-methylpentyne-3,4-diolJ Grove, B K Martin
Psychiatry, Psychology, and Law : an Interdisciplinary Journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law|October 29, 2021
Do laypeople recognize youth as a risk factor for false confession? A test of the 'common sense' hypothesisLauren J Grove, Jeff Kukucka
SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance|April 10, 2026
Interventions currently implemented among orphans in South-Africa: a scoping reviewMartin J Grove, Ruan Spies
Science (New York, N.Y.)|August 25, 1972
Genetic determination of phenotypic variation in sickle cell traitW E Nance, J Grove
Biochemical Pharmacology|July 22, 1992
The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liverM I Walton, C R Wolf, P Workman
British Journal of Cancer|March 1, 1991
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionH M Coley, P Workman, P R Twentyman
British Journal of Cancer|March 1, 1978
Different esterase activities of exponential and plateau phases of EMT6 cells monitored by flow cytofluorimetryJ V Watson, P Workman, S H Chambers
Seminars in Cancer Biology|December 1, 1992
Tyrosine kinase inhibitorsP Workman, V G Brunton, D J Robins
Biochemical Pharmacology|December 15, 1989
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin AH M Coley, P R Twentyman, P Workman
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokineticsH F Newman, N M Bleehen, P Workman
Pageof 38